1. Home
  2. NLSP vs MVBF Comparison

NLSP vs MVBF Comparison

Compare NLSP & MVBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • MVBF
  • Stock Information
  • Founded
  • NLSP 2015
  • MVBF 1997
  • Country
  • NLSP Switzerland
  • MVBF United States
  • Employees
  • NLSP N/A
  • MVBF 445
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • MVBF Major Banks
  • Sector
  • NLSP Health Care
  • MVBF Finance
  • Exchange
  • NLSP Nasdaq
  • MVBF Nasdaq
  • Market Cap
  • NLSP 243.8M
  • MVBF 242.5M
  • IPO Year
  • NLSP 2021
  • MVBF N/A
  • Fundamental
  • Price
  • NLSP $4.90
  • MVBF $18.76
  • Analyst Decision
  • NLSP
  • MVBF Buy
  • Analyst Count
  • NLSP 0
  • MVBF 2
  • Target Price
  • NLSP N/A
  • MVBF $27.00
  • AVG Volume (30 Days)
  • NLSP 26.6K
  • MVBF 27.0K
  • Earning Date
  • NLSP 10-11-2024
  • MVBF 10-24-2024
  • Dividend Yield
  • NLSP N/A
  • MVBF 3.63%
  • EPS Growth
  • NLSP N/A
  • MVBF N/A
  • EPS
  • NLSP N/A
  • MVBF 1.56
  • Revenue
  • NLSP N/A
  • MVBF $143,783,000.00
  • Revenue This Year
  • NLSP N/A
  • MVBF N/A
  • Revenue Next Year
  • NLSP N/A
  • MVBF $8.72
  • P/E Ratio
  • NLSP N/A
  • MVBF $12.03
  • Revenue Growth
  • NLSP N/A
  • MVBF 5.85
  • 52 Week Low
  • NLSP $4.08
  • MVBF $17.51
  • 52 Week High
  • NLSP $40.60
  • MVBF $25.24
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 37.46
  • MVBF 39.17
  • Support Level
  • NLSP $4.72
  • MVBF $18.40
  • Resistance Level
  • NLSP $5.50
  • MVBF $19.44
  • Average True Range (ATR)
  • NLSP 0.65
  • MVBF 0.48
  • MACD
  • NLSP 0.02
  • MVBF -0.09
  • Stochastic Oscillator
  • NLSP 28.47
  • MVBF 12.33

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About MVBF MVB Financial Corp.

MVB Financial Corp is a bank holding company. The company provides community banking, mortgage banking, insurance and wealth management services to individuals and corporate clients in the Mid-Atlantic region. The Bank offers its customers various products, such as checking accounts, negotiable order of withdrawal (NOW) accounts, money market and savings accounts, time certificates of deposit, commercial, installment, commercial real estate and residential real estate mortgage loans, debit cards, and safe deposit rental facilities. MVB has three reportable segments: CoRe banking; mortgage banking and the financial holding company. It generates majority of its revenues from its CoRe banking segment.

Share on Social Networks: